Target intelligence / Profile preview

Dynein light chain roadblock-type 2 (DYNLRB2)

Target
DYNLRB2
Molecular classification
Other (non-catalytic accessory protein), Cytoplasmic dynein complex subunit
01

Overview

Dynein light chain roadblock-type 2 (DYNLRB2) is a non-catalytic accessory component of the cytoplasmic dynein 1 complex, which acts as a motor for retrograde transport of vesicles and organelles along microtubules[2][3][6]. DYNLRB2 is specifically upregulated in testis tissue at the protein level and is indispensable for proper spindle formation during male meiosis I, where it helps maintain the integrity of spindle poles by inhibiting pericentriolar material (PCM) fragmentation and recruiting proteins critical for spindle pole function, such as NuMA[1]. DYNLRB2 binds to the dynein intermediate chain and functions in a tissue-specific manner, with its expression mutually exclusive to its paralog DYNLRB1, which is present in somatic, mitotic cells. Dysregulation or loss of DYNLRB2 in mice leads to arrested meiosis and abnormal spindle formation, highlighting its role in cell division. Disease associations include links to certain syndromes and possible use as a cancer biomarker, but no drugs are specifically known to directly target DYNLRB2[1][2].

Other names
Dynein light chain roadblock-type 2DYNLRB2DNCL2BDNLC2BROBLD2Dynein light chain 2B, cytoplasmicRoadblock domain-containing protein 2roadblock domain containing 2bithoraxoid-like proteintesticular tissue protein Li 53
02

Biological functions

Microtubule-based movementRegulation of spindle formation (especially in male meiosis)Dynein intermediate chain bindingOrganelle and vesicle transport
03

Disease associations

Deafness (autosomal recessive 77)Bardet-Biedl syndrome 1Potential biomarker in hepatocellular carcinoma (according to limited data)
04

Biomarkers

Hepatocellular carcinoma (as a biomarker; limited evidence)

Beyond the preview

Go deeper on Dynein light chain roadblock-type 2 (DYNLRB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynein light chain roadblock-type 2 (DYNLRB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call